Search All UT System Experts

Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461

John C. Byrd, Amy S. Ruppert, Krzysztof Mrózek, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Judith Stamberg, Prasad R K Koduru, Joseph O. Moore, Robert J. Mayer, Frederick R. Davey, Richard A. Larson, Clara D. Bloomfield

Research output: Contribution to journal › Article › peer-review

177 Scopus citations

Fingerprint

Dive into the research topics of 'Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461'. Together they form a unique fingerprint.

Medicine & Life Sciences